Erector Spinae Plane Block vs. Usual Care for ED Patients With Mechanical Back Pain

NCT ID: NCT05982483

Last Updated: 2023-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-08

Study Completion Date

2023-01-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare the Erector Spinae plane (ESP) block, a nerve block, to usual care in emergency department patients with back pain. The main question it aims to answer:

Is the ESP block superior to usual care in the treatment of back pain in the emergency department? Participants will be randomly assigned to the ESP or the usual care group. Pain improvement at the time of emergency department discharge will be compared.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Outcome Assessors
Participants in both cohorts had pink chlorhexidine skin prep and a dressing applied to the back. Research team members performing the telephone follow-up were blinded to treatment allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ESP cohort

Randomized to receive the ultrasound-guided ESP block.

Group Type EXPERIMENTAL

Erector Spinae plane block using 20 ml of bupivicaine 0.25%

Intervention Type PROCEDURE

Utilizing the in line approach, a 22 gauge 3.5" spinal needle was guided the the tip of the transverse process corresponding to the area of maximal tenderness or central to the reported area of spasm. 1% lidocaine with epinephrine was used for skin anaesthesia and for hydro-localization of the needle tip on approach to the tip of the transverse process. Once the needle tip made contact with the transverse process, 2-3 ml of 1% lidocaine with epinephrine was injected to open the ESP plane. If there was no reported tachycardia after approximately 45 seconds, 20 ml of 0.25% bupivicaine was injected into the ESP plane.

Usual care cohort

Randomized to usual care as dictated by the treating emergency physician

Group Type ACTIVE_COMPARATOR

Usual care

Intervention Type DRUG

Analgesia as dictated by the treating emergency physician

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erector Spinae plane block using 20 ml of bupivicaine 0.25%

Utilizing the in line approach, a 22 gauge 3.5" spinal needle was guided the the tip of the transverse process corresponding to the area of maximal tenderness or central to the reported area of spasm. 1% lidocaine with epinephrine was used for skin anaesthesia and for hydro-localization of the needle tip on approach to the tip of the transverse process. Once the needle tip made contact with the transverse process, 2-3 ml of 1% lidocaine with epinephrine was injected to open the ESP plane. If there was no reported tachycardia after approximately 45 seconds, 20 ml of 0.25% bupivicaine was injected into the ESP plane.

Intervention Type PROCEDURE

Usual care

Analgesia as dictated by the treating emergency physician

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* previous recipient of erector spinae plane block
* exam concerning for cauda equina syndrome
* current IV drug use
* organ transplant recipient
* history of or suspected bleeding diathesis
* current use of anticoagulants
* sepsis or soft tissue infection at site of the block within last three months
* pregnancy
* overt malignancy involving skin or underlying soft tissue at the site of block
* allergy to any of the research medications
* inability to participate in telephone follow-up
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Island Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ben Ho

Emergency department staff physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nanaimo Regional General Hospital

Nanaimo, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Ho B, Fyfe-Brown R, Chopra S, McMeel K. The erector spinae plane block vs. usual care for treatment of mechanical back pain in the emergency department: a pilot study. CJEM. 2024 Aug;26(8):543-548. doi: 10.1007/s43678-024-00748-7. Epub 2024 Jul 31.

Reference Type DERIVED
PMID: 39083200 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C2018-102

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

IV Lidocaine in Pediatric AIS
NCT03893318 TERMINATED PHASE4
Spasmodic Dysphonia Pain
NCT04648891 COMPLETED PHASE2/PHASE3
Nitrous Oxide for Lumbar Puncture
NCT03228628 UNKNOWN PHASE4